BRISTOL-MYERS SQUIBB PHARMA COMPANY
Patent Owner
Stats
- 339 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 18, 2010 most recent publication
Details
- 339 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 10,208 Total Citation Count
- Oct 15, 1981 Earliest Filing
- 247 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7662817 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligandsFeb 13, 08Feb 16, 10[A61K, C07D, A61P]
7655647 Substituted lactams as inhibitors of Aβ protein productionFeb 19, 09Feb 02, 10[A61K, C07D, A61P]
7456172 Succinoylamino benzodiazepines as inhibitors of A.beta. protein productionJan 13, 06Nov 25, 08[A61P]
7442792 Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereofMar 13, 07Oct 28, 08[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7718795 Succinoylamino benzodiazepines as inhibitors of aβ protein productionExpiredApr 02, 08May 18, 10[C07D]
2010/0069,373 SUBSTITUTED LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTIONAbandonedNov 10, 09Mar 18, 10[A61K, C07D, A61P]
2010/0056,501 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTIONAbandonedSep 22, 09Mar 04, 10[A61K, C07D, A61P]
2010/0048,541 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTIONAbandonedSep 17, 09Feb 25, 10[A61K, C07D]
2010/0041,639 CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTIONAbandonedOct 21, 09Feb 18, 10[A61K, C07D, A61P]
2010/0009,965 CYCLIC MALONAMIDES AS INHIBITORS OF ABETA PROTEIN PRODUCTIONAbandonedSep 02, 09Jan 14, 10[A61K, C07D]
2010/0009,966 SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTIONAbandonedSep 15, 09Jan 14, 10[A61K, C07D, A61P]
2009/0264,419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTIONAbandonedMay 01, 09Oct 22, 09[A61K, C07D, A61P]
2009/0111,793 HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF A BETA PROTEIN PRODUCTIONAbandonedSep 09, 08Apr 30, 09[A61K, C07D, A61P]
7507815 Succinoylamino lactams as inhibitors of a-β protein productionExpiredDec 04, 07Mar 24, 09[C07D]
2009/0069,293 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF AB PROTEIN PRODUCTIONAbandonedOct 20, 08Mar 12, 09[A61K, C07D]
2009/0062,256 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTIONAbandonedOct 24, 08Mar 05, 09[A61K, C07D, A61P]
7498324 Substituted lactams as inhibitors of Aβ protein productionExpiredApr 19, 07Mar 03, 09[A61K, C07D]
7456278 Lactams substituted by cyclic succinates as inhibitors of A.beta. protein productionExpiredOct 31, 07Nov 25, 08[C07D]
7423033 Hydroxyalkanoylaminolactams and related structures as inhibitors of a.beta. protein productionExpiredFeb 01, 08Sep 09, 08[C07D]
2008/0213,181 Preparation of Paramagnetic Nanoparticles Conjugated to Leukotriene B4 (LTB4) Receptor Antagonists, and Their Use as MRI Contrast Agents for the Detection of Infection and InflammationAbandonedDec 19, 07Sep 04, 08[A61K, C07D]
2008/0171,735 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTIONAbandonedMar 10, 08Jul 17, 08[A61K, C07D]
2007/0238,136 ASSAYS AND PEPTIDE SUBSTRATE FOR DETERMINING AGGRECAN DEGRADING METALLO PROTEASE ACTIVITYAbandonedApr 10, 07Oct 11, 07[C12Q, G01N]
7223834 Assays and peptide substrate for determining aggrecan degrading metallo protease activityExpiredOct 12, 01May 29, 07[A61K]
2006/0211,679 Substituted lactams as inhibitors of Abeta protein productionAbandonedFeb 06, 06Sep 21, 06[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
